Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a multicentre, randomised, double-blind phase 3 trial

Scientific publication - Journal Article uoadl:2950868 66 Read counter

Unit:
Faculty of Medicine
Title:
Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a multicentre, randomised, double-blind phase 3 trial
Languages of Item:
English
Abstract:
Empty abstract
Publication year:
2014
Authors:
San-Miguel, Jesús F
Hungria, Vania TM
Yoon, Sung-Soo
Beksac, Meral
Dimopoulos, Meletios Athanasios
Elghandour, Ashraf
Jedrzejczak, Wieslaw Wiktor
Günther, Andreas
Nakorn, Thanyaphong Na
Siritanaratkul, Noppadol
others
Journal:
The lancet oncology
Publisher:
Elsevier
Volume:
15
Number:
11
Pages:
1195--1206
Main subject category:
Health Sciences
The digital material of the item is not available.